These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33330020)

  • 1. Brainstem NTCP and Dose Constraints for Carbon Ion RT-Application and Translation From Japanese to European RBE-Weighted Dose.
    Dale JE; Molinelli S; Vischioni B; Vitolo V; Bonora M; Magro G; Mairani A; Hasegawa A; Ohno T; Dahl O; Valvo F; Fossati P
    Front Oncol; 2020; 10():531344. PubMed ID: 33330020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
    Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
    Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBE-weighted dose conversions for patients with recurrent nasopharyngeal carcinoma receiving carbon-ion radiotherapy from the local effect model to the microdosimetric kinetic model.
    Zhang L; Wang W; Hu J; Lu J; Kong L
    Radiat Oncol; 2020 Dec; 15(1):277. PubMed ID: 33302998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organs at risk dose constraints in carbon ion radiotherapy at MedAustron: Translations between LEM and MKM RBE models and preliminary clinical results.
    Grosshagauer S; Fossati P; Schafasand M; Carlino A; Poljanc K; Radakovits T; Stock M; Hug E; Georg P; Pelak M; Góra J
    Radiother Oncol; 2022 Oct; 175():73-78. PubMed ID: 35952977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sensitivity of radiobiological models in carbon ion radiotherapy (CIRT) and its consequences on the clinical treatment plan: Differences between LEM and MKM models.
    Góra J; Grosshagauer S; Fossati P; Mumot M; Stock M; Schafasand M; Carlino A
    J Appl Clin Med Phys; 2024 Jul; 25(7):e14321. PubMed ID: 38436509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBE-weighted dose conversions for carbon ionradiotherapy between microdosimetric kinetic model and local effect model for the targets and organs at risk in prostate carcinoma.
    Wang W; Huang Z; Sheng Y; Zhao J; Shahnazi K; Zhang Q; Jiang G
    Radiother Oncol; 2020 Mar; 144():30-36. PubMed ID: 31710941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic nerve constraints for carbon ion RT at CNAO - Reporting and relating outcome to European and Japanese RBE.
    Dale JE; Molinelli S; Vitolo V; Vischioni B; Bonora M; Magro G; Pettersen HES; Mairani A; Hasegawa A; Dahl O; Valvo F; Fossati P
    Radiother Oncol; 2019 Nov; 140():175-181. PubMed ID: 31310888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity study of the microdosimetric kinetic model parameters for carbon ion radiotherapy.
    Dahle TJ; Magro G; Ytre-Hauge KS; Stokkevåg CH; Choi K; Mairani A
    Phys Med Biol; 2018 Nov; 63(22):225016. PubMed ID: 30418940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the relative biological effectiveness of active-energy scanning carbon-ion radiotherapy on a commercial treatment planning system with a microdosimetic kinetic model.
    Wang W; Sun W; Shen H; Zhao J
    Radiat Oncol; 2023 May; 18(1):82. PubMed ID: 37198685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FRoG-A New Calculation Engine for Clinical Investigations with Proton and Carbon Ion Beams at CNAO.
    Choi K; Mein SB; Kopp B; Magro G; Molinelli S; Ciocca M; Mairani A
    Cancers (Basel); 2018 Oct; 10(11):. PubMed ID: 30360576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectum Dose Constraints for Carbon Ion Therapy: Relative Biological Effectiveness Model Dependence in Relation to Clinical Outcomes.
    Choi K; Molinelli S; Russo S; Mirandola A; Fiore MR; Vischioni B; Fossati P; Petrucci R; Turturici I; Dale JE; Valvo F; Ciocca M; Mairani A
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon-ion radiotherapy (CIRT) as treatment of pancreatic cancer at HIT: initial radiation plan analysis of the prospective phase II PACK-study.
    Baltazar F; Tessonnier T; Haberer T; Debus J; Herfarth K; Tawk B; Knoll M; Abdollahi A; Liermann J; Mairani A
    Radiother Oncol; 2023 Nov; 188():109872. PubMed ID: 37634764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
    Gillmann C; Jäkel O; Schlampp I; Karger CP
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose prescription in carbon ion radiotherapy: How to compare two different RBE-weighted dose calculation systems.
    Molinelli S; Magro G; Mairani A; Matsufuji N; Kanematsu N; Inaniwa T; Mirandola A; Russo S; Mastella E; Hasegawa A; Tsuji H; Yamada S; Vischioni B; Vitolo V; Ferrari A; Ciocca M; Kamada T; Tsujii H; Orecchia R; Fossati P
    Radiother Oncol; 2016 Aug; 120(2):307-12. PubMed ID: 27394694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RBE-weighted dose in carbon ion therapy for ACC patients: Impact of the RBE model translation on treatment outcomes.
    Molinelli S; Bonora M; Magro G; Casale S; Dale JE; Fossati P; Hasegawa A; Mirandola A; Ronchi S; Russo S; Preda L; Valvo F; Orecchia R; Ciocca M; Vischioni B
    Radiother Oncol; 2019 Dec; 141():227-233. PubMed ID: 31522881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiobiological issues in prospective carbon ion therapy trials.
    Fossati P; Matsufuji N; Kamada T; Karger CP
    Med Phys; 2018 Nov; 45(11):e1096-e1110. PubMed ID: 30421806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and α/β = 2 Gy overestimates the RBE.
    Eichkorn T; Karger CP; Brons S; Koerber SA; Mielke T; Haberer T; Debus J; Herfarth K
    Radiother Oncol; 2022 Aug; 173():223-230. PubMed ID: 35714806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBE-weighted doses in target volumes of chordoma and chondrosarcoma patients treated with carbon ion radiotherapy: Comparison of local effect models I and IV.
    Gillmann C; Jäkel O; Karger CP
    Radiother Oncol; 2019 Dec; 141():234-238. PubMed ID: 31522880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy.
    Fossati P; Molinelli S; Matsufuji N; Ciocca M; Mirandola A; Mairani A; Mizoe J; Hasegawa A; Imai R; Kamada T; Orecchia R; Tsujii H
    Phys Med Biol; 2012 Nov; 57(22):7543-54. PubMed ID: 23104051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated carbon ion irradiations of the rat spinal cord: comparison of the relative biological effectiveness with predictions of the local effect model.
    Saager M; Glowa C; Peschke P; Brons S; Grün R; Scholz M; Debus J; Karger CP
    Radiat Oncol; 2020 Jan; 15(1):6. PubMed ID: 31900185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.